Opioid Maker Funds Efforts To Fight Addiction: Is It ‘Blood Money’ Or Charity?
Purdue Pharma, whose signature product helped fuel the opioid epidemic, now wants to help treat it — or at least salvage its own reputation.
The independent source for health policy research, polling, and news.
761 - 780 of 1,046 Results
Purdue Pharma, whose signature product helped fuel the opioid epidemic, now wants to help treat it — or at least salvage its own reputation.
The research, focused on Los Angeles County, casts a positive light on a 2004 initiative that expanded mental health services statewide. A recent state audit, however, suggested hundreds of millions of dollars from the initiative were piling up, left unspent by counties.
Starting this spring, aspiring doctors at the Oregon Health & Science University must prove they can communicate about difficult subjects ranging from admitting medical mistakes to notifying families about a patient’s death.
An addiction-treatment physician fatally shot a troubled ex-Marine after the man pummeled him inside his California office, police records show. The tragedy illustrates how the limited number of clinics available to prescribe buprenorphine, a drug that all but erases opioid withdrawal, can become crowded, chaotic and dangerous.
The effort, overseen by the county’s health services department, aims to improve care for a population with high rates of chronic disease, mental illness and drug addiction.
Seniors face tough — often life-changing — events throughout their final years. But this stage of life does not have to be limited to loss and deterioration.
The same Florida bill that would put more guns in schools would provide the state with $90 million more for mental health resources, including $69 million for schools. Advocates say those funds for mental health care are desperately needed.
The makers of the Montreal Cognitive Assessment, or MoCA, say the test wasn’t meant for the masses. Now they’re working on a “mini-MoCA” that people who are worried about possible dementia can take online.
The collaboration known as ALTO, Alternatives to Opioids, set out to reduce opioid doses in the emergency room by 15 percent. It managed a 36 percent reduction instead.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Stephanie Armour of The Wall Street Journal and Julie Appleby of Kaiser Health News discuss the Trump administration’s proposed regulation that would allow the expansion of short-term health insurance policies that do not comply with all the requirements of the Affordable Care Act. The panelists also talk about federal funding (or not) of public health research around guns.
Christine Sylvest, a child psychologist who now works in Maryland, for three years attended the Parkland, Fla., high school where a shooting attack left 17 people dead last week. She says the tragedy affects the entire community.
A package of mental health bills in California aims to ensure that all new moms are screened for postpartum depression and that more support is available for those who struggle with the malady.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Fentanyl, a significant cause of overdoses and deaths across the country, has begun showing up in California street drugs. State health officials have responded with a bold but controversial policy: paying for test strips so users can check their stash.
Andrey Ostrovsky, who until last month was chief medical officer for Medicaid, quit his job so he could more directly fight the stigma of drug addiction.
Health care professionals increasingly collaborate with anti-abuse advocates to identify victims and ensure they get the help they need. One women’s center is opening a shelter on the campus of a large public hospital in Los Angeles.
Philadelphia officials gave the OK to establishing safe-injection sites for drug users. But it's unclear where the sites would be located and who would fund and operate them.
At a panel discussion this week in Sacramento, patients, caregivers and others shared their perspectives on how Alzheimer’s disease affects women, who account for two-thirds of those living with the condition.
"We really do have a lot of responsibility and culpability," says one hospital official who is part of a working group trying to address the opioid epidemic. Patients have to expect more pain after surgery and understand the risk of addiction, says another doctor.
Few bonds are as tight as those between sisters. But when one has paranoid schizophrenia, the relationship grows complicated.
© 2026 KFF